Quarterly report [Sections 13 or 15(d)]

Summary of Purchase Price Acquisition (Details) (Parenthetical)

v3.26.3
Summary of Purchase Price Acquisition (Details) (Parenthetical) - Series A Preferred Stock [Member] - Vidya Therapeutics, Inc. [Member]
Jul. 28, 2026
shares
Asset Acquisition [Line Items]  
Conversion of shares 1,000
Conversion of preferred stock, shares 1